Since the inception of the UAB CFAR, the DNA Sequencing Core has provided CFAR members with state of- the-art Sanger DNA sequencing and bioinformatics analytical capabilities. In order for CFAR investigators to meet the challenges of HIV/AIDS research in the treatment era, it was necessary to refine and expand the services provided by the Core. The overall goal of the new CFAR Genomics Core is to provide its investigators access to cutting-edge genomics resources and methodologies designed to facilitate HIV/AIDS related research.
Specific Aims of the Genomic Core are;1. Provide genetic and genomic analysis services, including, but not limited to, Sanger DNA Sequencing, Next Generation sequencing, and microarrays to CFAR investigators. The Genomics component of the core will continue to provide access to state-of-the art genomic technologies, including traditional Sanger DNA sequencing. It will also continue its strong educational component by providing consultative services for the use of high dimensional genomic technologies. 2. Provide state-of-the-art microbiome analysis services to CFAR investigators. The gut microbiome has a major impact on diseases that afflict people with HIV/AIDS including obesity, cardiovascular disease and cancer. The new Microbiome service will provide assistance with experimental design, sample collection and preparation, sequencing and bioinformatics analysis. We have started this program and have already provided service to 19 CFAR members for results that were included in 10 internal and external grant submissions in the first and only year. 3. Provide computational resources and bioinformatics support to assist CFAR investigators in the analysis and understanding of genomic and microbiome data. The Bioinformatics component will continue to provide CFAR investigators with all of the resources necessary to fully support the wide range of informatics needs. Our services provide: 1) access to information;2) access to tools;and 3) research and educational support. 4. Act as a platform for promoting multi-disciplinary research and provide advice and training to CFAR pre- and post-doctoral trainees, pilot project awardees, and investigators regarding general aspects of microbiome and genomics, as well as information on specific measurements, assays, and technologies.

Public Health Relevance

The Genomics Core with new/microbiome and genomic services, coupled with the continued services of Sanger DNA sequencing and computational and bioinformatics support, provides CFAR investigators with unique resources to facilitate research in prevention, pathogenesis, drug discovery and the natural history in the treatment era for HIV/AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027767-26
Application #
8697466
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
26
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Salazar-Gonzalez, Jesus F; Salazar, Maria G; Tully, Damien C et al. (2016) Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes. Pathog Immun 1:129-153
Abedini-Nassab, Roozbeh; Joh, Daniel Y; Van Heest, Melissa et al. (2016) Magnetophoretic Conductors and Diodes in a 3D Magnetic Field. Adv Funct Mater 26:4026-4034
Dalecki, Alex G; Malalasekera, Aruni P; Schaaf, Kaitlyn et al. (2016) Combinatorial phenotypic screen uncovers unrecognized family of extended thiourea inhibitors with copper-dependent anti-staphylococcal activity. Metallomics 8:412-21
Pettit, April C; Mendes, Adell; Jenkins, Cathy et al. (2016) Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment. J Acquir Immune Defic Syndr 72:572-8
Friedman, Gregory K; Moore, Blake P; Nan, Li et al. (2016) Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses. Neuro Oncol 18:227-35
Demark-Wahnefried, Wendy; Nix, Jeffery W; Hunter, Gary R et al. (2016) Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for BMC Cancer 16:61
Merlin, Jessica S; Tamhane, Ashutosh; Starrels, Joanna L et al. (2016) Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIV. AIDS Behav 20:687-98
Khan, Shahzada; Woodruff, Erik M; Trapecar, Martin et al. (2016) Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J Exp Med 213:2913-2929
Kumar, Ashish; Zhang, Jennifer; Tallaksen-Greene, Sara et al. (2016) Allelic series of Huntington's disease knock-in mice reveals expression discorrelates. Hum Mol Genet 25:1619-36
Qin, Hongwei; Buckley, Jessica A; Li, Xinru et al. (2016) Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. J Neurosci 36:5144-59

Showing the most recent 10 out of 784 publications